Legalising lower dosage cannabis products could 'ignite industry'

Mitch Cuevas, pharmaceutical director at Katikati based medicinal cannabis firm Eqalis, said NZ is 'missing out' on an obvious export opportunity. (Image: Eqalis)

Brent Melville

Tue, 15 Feb 2022

Easing restrictions on low-level cannabidiol (CBD) for over-the-counter sales could boost cannabis earnings fourfold, creating a $2 billion sector within the next eight years, a new report says.Dr Nick Marsh, an analyst and consultant with Next Corp, said regulatory reform allowing expanded use of low potency CBD for nutraceuticals and food products could ignite the industry’s earning power.In New Zealand, any strength CBD is scheduled as a restricted medicine under the Medicines Act and therefore must be prescribed by a medical professio...

Unlock all stories free for 10 days

Stay informed on business, government and financial developments across New Zealand.

Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

We won’t charge for 10 days. You can cancel anytime with two clicks, an email or a phone call. Find out more.

We are serious about journalism.

Name {{ registerForm.errors.get('name') }}

Email address {{ registerForm.errors.get('email') }}

Phone Number {{ registerForm.errors.get('phone') }}

Job Title {{ registerForm.errors.get('title') }}

Password Minimum password length of 8 characters.
Require at least one upper and lowercase, numeric, and special character. {{ registerForm.errors.get('password') }}

Repeat password {{ registerForm.errors.get('password_confirmation') }}

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Credit Card

Cardholder's name

{{ __(plans[index].interval) | capitalize }} {{ plans[index].attributes.old_price | currency }} {{ plans[index].price | currency }}

You will be charged in 10 days unless you cancel beforehand.
We will remind you three times before charging you.
All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service

{{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

Finance

$1.65b project to simplify switching banks a 'flop'

Open banking has hindered competition rather than helping it, says lobby.

AAP 11:00am

Markets

Infratil's CDC investment cracks $5 billion mark

Surging datacentre demand and expanded development plans benefit Infratil.

Rebecca Stevenson 10:10am

Infratil's CDC investment cracks $5 billion mark

Economy

Albanese pledges prosperity through manufacturing boost

Renewable energy and critical minerals key focus of $24 billion strategy.

AAP 10:00am

Albanese pledges prosperity through manufacturing boost

Sponsored

Smart chargers don't just charge EVs

They also take the pressure off a stressed power network - We.EV

We.EV

Sponsored

Big change coming to insurance

Industry reset sees risk-based pricing coming for many homeowners.

VERO

More Health

News in Brief

Kiwibank director joins Evolution Healthcare as chair

Scott Pickering has been appointed chair of Evolution Healthcare and director of Fidelity Life.Evolution Healthcare is a private healthcare operator and Fidelity Life is New Zealand’s largest locally-owned life insurer.His position at Evolution Healthcare began on Monday and the...

Staff reporters 01 Jul 2024